GlassScriptPrepare for your visit
Laila Babar
Hematology & Oncology · Oklahoma City, OK · NPI 1760907513
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,280.51
in general payments reported to CMS, 2019-2025 · $612 in 2025
The $612 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Who reported paying
General payments only, top 6 by amount.
- Galvanize Therapeutics, INC $176.58
- Caris Mpi, INC. $174.00
- E.R. Squibb & Sons, L.L.C. $150.23
- Intuitive Surgical, INC. $106.87
- Jazz Pharmaceuticals INC. $99.06
- Daiichi Sankyo INC. $73.93
Drugs and devices associated with these payments
Aliya System Mi Cancer Seek Da Vinci Surgical System Doptelet Sarclisa Kisqali Opdivo Enhertu Carvykti Talvey Tecvayli Darzalex
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Laila Babar listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/3712859/laila-babar